How severe is CVE-2022-26041?

CVE-2022-26041 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires high privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability none.

Is CVE-2022-26041 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (70th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2022-26041?

CVE-2022-26041 affects Generex Rccmd. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2022-26041?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2022-26041 published?

CVE-2022-26041 was published on 2022-06-13 and last updated on 2026-06-17.

CVE-2022-26041

CVE-2022-26041 is a medium-severity vulnerability in Generex Rccmd with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-22.

Key facts

Severity: Medium (CVSS 3.x base score 6.5)
CVSS v2: 5.5
EPSS exploit prediction: 1% (70th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-22
Affected product: Generex Rccmd
Published: 2022-06-13
Last modified: 2026-06-17

Description

Directory traversal vulnerability in RCCMD 4.26 and earlier allows a remote authenticated attacker with an administrative privilege to read or alter an arbitrary file on the server via unspecified vectors.

Frequently asked questions

What is CVE-2022-26041?: Directory traversal vulnerability in RCCMD 4.26 and earlier allows a remote authenticated attacker with an administrative privilege to read or alter an arbitrary file on the server via unspecified vectors.
How severe is CVE-2022-26041?: CVE-2022-26041 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires high privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability none.
Is CVE-2022-26041 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (70th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-26041?: CVE-2022-26041 affects Generex Rccmd. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-26041?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2022-26041 published?: CVE-2022-26041 was published on 2022-06-13 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:generex:rccmd:*:*:*:*:*:*:*:*

Other CWE-22 (Path Traversal) vulnerabilities

CVE-2026-48282 — Critical (CVSS 10.0): ColdFusion versions 2025.9, 2023.20 and earlier are affected by an Improper Limitation of a Pathname to a Restricted…
CVE-2026-54917 — Critical (CVSS 10.0): SeaweedFS is a distributed storage system for object storage (S3), file systems, and Iceberg tables. Prior to 4.30, the…
CVE-2026-11429 — Critical (CVSS 10.0): Two endpoints in the Vault Service ScriptsController, shared by Altium Enterprise Server and Altium 365, accept file…
CVE-2026-34909 — Critical (CVSS 10.0): A malicious actor with access to the network could exploit a Path Traversal vulnerability found in UniFi OS devices to…
CVE-2026-7411 — Critical (CVSS 10.0): In Eclipse BaSyx Java Server SDK versions prior to 2.0.0-milestone-10, inadequate path normalization in the Submodel…
CVE-2026-36767 — Critical (CVSS 10.0): A path traversal vulnerability in the /content/images/add endpoint of shopizer v3.2.5 allows attackers write arbitrary…

Browse all CWE-22 (Path Traversal) vulnerabilities →